tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

SVRA Stock Latest News

Savara Re-elects Board Members at Annual Meeting
Company AnnouncementsSavara Re-elects Board Members at Annual Meeting
1d ago
8K
SVRA
Savara assumed with an Outperform at Oppenheimer
PremiumThe Fly
Savara assumed with an Outperform at Oppenheimer
6d ago
SVRA
Savara downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Savara downgraded to Neutral from Buy at H.C. Wainwright
10d ago
SVRA
Savara price target lowered to $2 from $3 at Evercore ISI
PremiumThe Fly
Savara price target lowered to $2 from $3 at Evercore ISI
11d ago
SVRA
Savara price target lowered to $8 from $9 at Guggenheim
PremiumThe Fly
Savara price target lowered to $8 from $9 at Guggenheim
11d ago
SVRA
Savara price target lowered to $7 from $8 at Wells Fargo
PremiumThe FlySavara price target lowered to $7 from $8 at Wells Fargo
11d ago
SVRA
U.S. extends EU tariff deadline, Salesforce to acquire Informatica: Morning Buzz
Premium
The Fly
U.S. extends EU tariff deadline, Salesforce to acquire Informatica: Morning Buzz
12d ago
X
TM
Savara Faces FDA Setback for MOLBREEVI Application
Premium
Company Announcements
Savara Faces FDA Setback for MOLBREEVI Application
12d ago
8K
SVRA
Savara receives RTF letter from FDA for Molbreevi BLA
PremiumThe Fly
Savara receives RTF letter from FDA for Molbreevi BLA
12d ago
SVRA
Savara announces new data in two poster presentations at ATS Conference 2025
PremiumThe Fly
Savara announces new data in two poster presentations at ATS Conference 2025
20d ago
SVRA
Savara’s Strategic Positioning and Financial Strength Drive Buy Rating Amid Anticipated Molbreevi Launch
PremiumRatings
Savara’s Strategic Positioning and Financial Strength Drive Buy Rating Amid Anticipated Molbreevi Launch
25d ago
SVRA
Savara price target lowered to $9 from $10 at Citizens JMP
PremiumThe Fly
Savara price target lowered to $9 from $10 at Citizens JMP
25d ago
SVRA
Savara reports Q1 EPS (12c), consensus (13c)
PremiumThe FlySavara reports Q1 EPS (12c), consensus (13c)
25d ago
SVRA
Savara announces encore presentations from Molgramostim Phase 3 IMPALA-2 trial
Premium
The Fly
Savara announces encore presentations from Molgramostim Phase 3 IMPALA-2 trial
2M ago
SVRA
Savara’s Strategic Advancements and Market Potential of Molbreevi: A Transformative Approach to aPAP Treatment
Premium
Ratings
Savara’s Strategic Advancements and Market Potential of Molbreevi: A Transformative Approach to aPAP Treatment
2M ago
SVRA
Savara’s Strategic Positioning and Market Potential for Molbreevi in aPAP Treatment
PremiumRatings
Savara’s Strategic Positioning and Market Potential for Molbreevi in aPAP Treatment
2M ago
SVRA
Savara reports Q4 EPS (13c), consensus (11c)
PremiumThe Fly
Savara reports Q4 EPS (13c), consensus (11c)
2M ago
SVRA
Savara Secures $200 Million Loan Agreement with Hercules
PremiumCompany Announcements
Savara Secures $200 Million Loan Agreement with Hercules
2M ago
8K
SVRA
Savara completes BLA submission to FDA for Molbreevi
PremiumThe Fly
Savara completes BLA submission to FDA for Molbreevi
2M ago
SVRA
Savara’s Innovative Testing and BLA Submission Drive Buy Rating Amid Market Growth Potential
PremiumRatingsSavara’s Innovative Testing and BLA Submission Drive Buy Rating Amid Market Growth Potential
3M ago
SVRA
Savara Sets 2025 Executive Bonus Targets
Premium
Company Announcements
Savara Sets 2025 Executive Bonus Targets
5M ago
8K
SVRA
Savara Highlights MOLBREEVI’s Potential in Rare Disease Market
Premium
Company Announcements
Savara Highlights MOLBREEVI’s Potential in Rare Disease Market
5M ago
8K
SVRA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >